KOMZIFTI (ziftomenib), the first and only once-daily oral menin inhibitor for adult patients with R/R AML with a susceptible NPM1 mutation who have no satisfactory alternative treatment options, has ...

KOMZIFTI, the first and only once-daily FDA-approved menin inhibitor for R/R NPM1-mutated AML, is now commercially available in the United States ...

Dr. Esosa Iriowen, Wilmington University’s (WilmU) Chair of Natural Sciences programs, goes by “Dr. E” for short — but that ...

Caitlin Clark and Sophie Cunningham joined the sports world in celebrating Nelly Korda’s surprise engagement to longtime ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

PEORIA — A new laboratory for a local biotech company received unanimous approval to move to a building in Central Peoria. Midwest Bioprocessing Center got a unanimous nod of approval from the Peoria ...

LOS ANGELES, Calif. – The National Science Foundation in Washington, D.C., has awarded Indian American Professor Dr. Chander Arora and the Los Angeles Mission College with a $509,000 Advanced ...

As the biopharma world predominantly invests in late-stage assets, Eli Lilly is prioritizing early science with the opening of a new Gateway Labs site, this time in Philadelphia. “We really like to ...

Precise Bio has reported the first successful human implantation of its 3D-printed cornea implant, constructed of functional human eye cells cultured in a laboratory. The company described the ...

While basic pizza dough is made with flour, water, yeast, salt and olive oil, the dough at Full Afterburner Calzones is made with five additional (top-secret) ingredients. The result is a super-thin, ...

Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial A recently approved antibody drug from Regeneron Pharmaceuticals eradicates residual traces of multiple myeloma ...